** Shares of healthcare technology co Aclarion ACON.O rise 68% to $5.61 premarket
** Co says it has entered into commercial agreement with Scripps Health
** The agreement will bring ACON's Nociscan, a tool that helps physicians personalize treatment for chronic low back pain, to Scripps' physicians in California
** In the last 12 months, ACON has fallen nearly 98%
(Reporting by Siddhi Mahatole)
((Siddhi.mahatole@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.